|
|
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History (PATH) |
| 1K23AG075261-01A1 |
|
NIA |
2022 |
|
|
A Randomized Trial of Gamification and Coaching to Improve Mobility after Hospitalization |
| 1R01AG071597-01A1 |
|
NIA |
2022 |
|
|
The Study of Muscle and Physical Performance in African Caribbeans. |
| 1R01AG074956-01 |
|
NIA |
2022 |
|
|
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. |
| 1R01AG074983-01 |
|
NIA |
2022 |
|
|
Impact of mitochondrial genetics on muscle oxidative capacity, fitness, and mobility in older adults |
| 1R01AG075081-01A1 |
|
NIA |
2022 |
|
|
Preoperative perturbation training to prevent falls after total knee arthroplasty |
| 1R01AG075098-01A1 |
|
NIA |
2022 |
|
|
Digital Markers of Mobility in Daily Life to Track Progression in Newly Diagnosed Parkinsons Disease |
| 1R01AG077380-01A1 |
|
NIA |
2022 |
|
|
Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial |
| 1R01AG078153-01 |
|
NIA |
2022 |
|
|
Predicting Functional Decline and Clinical Outcomes in Newly Diagnosed Older Patients with Localized Bladder Cancer |
| 1R03AG073990-01A1 |
|
NIA |
2022 |
|
|
FIsetin to Reduce Senescence and mobility impairmenT in PAD: the FIRST Pilot Randomized Trial |
| 1R21AG075613-01A1 |
|
NIA |
2022 |